Carronade Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-400,000
Closed -$2.79M 33
2024
Q2
$2.79M Hold
400,000
0.15% 29
2024
Q1
$4.24M Sell
400,000
-500,000
-56% -$4.37M 0.27% 20
2023
Q4
$7.22M Buy
900,000
+200,000
+29% +$1.46M 0.83% 17
2023
Q3
$5.75M Buy
+700,000
New +$6.03M 0.85% 24

Other funds holding BHC

Carronade Capital Management's BHC Position: Q3 2024 in Review

Carronade Capital Management sold out of Bausch Health (BHC) in Q3 2024, closing a stake of 62,841 shares — an estimated $438K sold.

Carronade Capital Management first reported a position in BHC in Q3 2023 and held it in 2 quarters. The position peaked at $6.58M in Q3 2023. 211 funds tracked by Wall St. Rank hold BHC as of Q3 2024.

  • Carronade Capital Management reported no remaining Bausch Health position as of Q3 2024 after selling out during the quarter.
  • Carronade Capital Management sold 62,841 Bausch Health shares in Q3 2024, an estimated $438K.
  • Carronade Capital Management first reported a position in Bausch Health in Q3 2023 and held it in 2 quarters.
  • Carronade Capital Management's Bausch Health position peaked at $6.58M in Q3 2023.
  • 211 funds tracked by Wall St. Rank held Bausch Health as of Q3 2024.

Based on Carronade Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.